As of 2025-09-17, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 640.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.86 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 9232.3%.
The range of the Relative Valuation is 413.90 - 908.97 USD.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 47.3x | 43.5x |
| Forward P/E multiples | 28.0x - 38.6x | 30.0x |
| Fair Price | 413.90 - 908.97 | 640.20 |
| Upside | 5933.5% - 13150.3% | 9232.3% |
| Date | P/E |
| 2025-09-11 | 0.37 |
| 2025-09-10 | 0.37 |
| 2025-09-09 | 0.37 |
| 2025-09-08 | 0.37 |
| 2025-09-05 | 0.37 |
| 2025-09-04 | 0.36 |
| 2025-09-03 | 0.36 |
| 2025-09-02 | 0.36 |
| 2025-08-29 | 0.37 |
| 2025-08-28 | 0.37 |
| 2025-08-27 | 0.37 |
| 2025-08-26 | 0.37 |
| 2025-08-25 | 0.36 |
| 2025-08-22 | 0.36 |
| 2025-08-21 | 0.37 |
| 2025-08-20 | 0.37 |
| 2025-08-19 | 0.38 |
| 2025-08-18 | 0.38 |
| 2025-08-15 | 0.38 |
| 2025-08-14 | 0.38 |
| 2025-08-13 | 0.39 |
| 2025-08-12 | 0.39 |
| 2025-08-11 | 0.38 |
| 2025-08-08 | 0.39 |
| 2025-08-07 | 0.39 |
| 2025-08-06 | 0.38 |
| 2025-08-05 | 0.38 |
| 2025-08-04 | 0.38 |
| 2025-08-01 | 0.38 |
| 2025-07-31 | 0.38 |
| 2025-07-30 | 0.38 |
| 2025-07-29 | 0.37 |
| 2025-07-28 | 0.38 |
| 2025-07-25 | 0.38 |
| 2025-07-24 | 0.38 |
| 2025-07-23 | 0.38 |
| 2025-07-22 | 0.38 |
| 2025-07-21 | 0.38 |
| 2025-07-18 | 0.39 |
| 2025-07-17 | 0.38 |
| 2025-07-16 | 0.37 |
| 2025-07-15 | 0.37 |
| 2025-07-14 | 0.37 |
| 2025-07-11 | 0.37 |
| 2025-07-10 | 0.37 |
| 2025-07-09 | 0.38 |
| 2025-07-08 | 0.38 |
| 2025-07-07 | 0.38 |
| 2025-07-03 | 0.38 |
| 2025-07-02 | 0.38 |